Inovio Pharmaceuticals Inc (INO)

[WWIII]

INO could go up big or could go down big.

I can see a $10 billion market cap potential for INO, therefore providing about $100/share. To me, it looks like their INO-5401 with checkpoint inhibitors could be a cure for many cancers. I have a concern that their immune boosting technology could over energize the immune system and lead to an autoimmune problem. I wonder about this because INO has developed a Humira equivalent which leads me to believe that they, at least at one point, considered their therapies to be overkill and needed something to slow down the attack of their immunotherapy products on healthy tissue. If I knew that INO did not have have an overly aggressive therapy, I would think they could have a market cap of $20 billion ($200/share) in five years. Any comment would be appreciated.